Genpact LTD Quarterly Cost of Revenue in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Genpact LTD quarterly/annual Cost of Revenue history and growth rate from Q1 2010 to Q3 2024.
  • Genpact LTD Cost of Revenue for the quarter ending September 30, 2024 was $780M, a 6.35% increase year-over-year.
  • Genpact LTD Cost of Revenue for the twelve months ending September 30, 2024 was $3.01B, a 4.44% increase year-over-year.
  • Genpact LTD annual Cost of Revenue for 2023 was $2.91B, a 2.52% increase from 2022.
  • Genpact LTD annual Cost of Revenue for 2022 was $2.83B, a 9.44% increase from 2021.
  • Genpact LTD annual Cost of Revenue for 2021 was $2.59B, a 7.12% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $3.01B $780M +$46.5M +6.35% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $2.97B $760M +$44.4M +6.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $2.92B $735M +$15.7M +2.18% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $2.91B $739M +$21.4M +2.98% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $2.88B $733M +$15.7M +2.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $2.87B $715M +$1.23M +0.17% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $2.87B $719M +$33.1M +4.83% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $2.83B $717M +$14.7M +2.09% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $2.82B $717M +$63.5M +9.72% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $2.76B $714M +$81.3M +12.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $2.68B $686M +$85M +14.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $2.59B $703M +$89M +14.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $2.5B $654M +$47.9M +7.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $2.45B $633M +$39.1M +6.58% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $2.41B $601M -$3.84M -0.64% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $2.42B $614M -$17M -2.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $2.44B $606M +$32.2M +5.61% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $2.4B $594M +$22.6M +3.97% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $2.38B $605M +$85.6M +16.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $2.29B $631M +$97.5M +18.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $2.2B $574M +$92.2M +19.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $2.1B $571M +$108M +23.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $2B $519M +$74.8M +16.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $1.92B $533M +$78.3M +17.2% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $1.84B $481M +$52.6M +12.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $1.79B $463M +$48.4M +11.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $1.74B $444M +$61M +15.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $1.68B $455M +$49.5M +12.2% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $1.63B $429M +$36.4M +9.27% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $1.6B $415M +$30.8M +8.01% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $1.56B $383M +$10.5M +2.81% Jan 1, 2017 Mar 31, 2017 8-K 2018-06-04
Q4 2016 $1.55B $405M +$11.4M +2.89% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 $1.54B $392M +$16.6M +4.42% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $1.53B $384M +$17.5M +4.76% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $1.51B $373M +$15.4M +4.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $1.49B $394M +$34.7M +9.67% Oct 1, 2015 Dec 31, 2015 8-K 2018-06-04
Q3 2015 $1.46B $376M +$21.4M +6.02% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $1.44B $366M +$26.2M +7.7% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $1.41B $357M +$33.2M +10.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $1.38B $359M +$13.4M +3.86% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $1.36B $354M +$25.2M +7.65% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $1.34B $340M +$7.41M +2.23% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $1.33B $324M +$12.6M +4.03% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $1.32B $346M +$36M +11.6% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 $1.28B $329M +$32M +10.8% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $1.25B $333M +$47.5M +16.7% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 $1.2B $312M +$46.3M +17.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 $1.16B $310M +$41.8M +15.6% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 $1.12B $297M +$28.9M +10.8% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $1.09B $285M +$31.2M +12.3% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $1.06B $265M +$51M +23.8% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $1B $268M +$52.2M +24.2% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-28
Q3 2011 $953M $268M +$63.5M +31% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $889M $254M +$62.9M +32.9% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $826M $214M +$37.8M +21.4% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q4 2010 $789M $216M Oct 1, 2010 Dec 31, 2010 10-K 2013-03-01
Q3 2010 $205M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 $191M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
Q1 2010 $177M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.